• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖酵解代谢物甲基乙二醛使 NLRP3 炎症小体失活。

The glycolytic metabolite methylglyoxal covalently inactivates the NLRP3 inflammasome.

机构信息

Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Molecular and Cellular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Department of Molecular and Cellular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Cell Rep. 2024 Sep 24;43(9):114688. doi: 10.1016/j.celrep.2024.114688. Epub 2024 Aug 27.

DOI:10.1016/j.celrep.2024.114688
PMID:39196782
Abstract

The NLRP3 inflammasome promotes inflammation in disease, yet the full repertoire of mechanisms regulating its activity is not well delineated. Among established regulatory mechanisms, covalent modification of NLRP3 has emerged as a common route for the pharmacological inactivation of this protein. Here, we show that inhibition of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1) results in the accumulation of methylglyoxal, a reactive metabolite whose increased levels decrease NLRP3 assembly and inflammatory signaling in cells. We find that methylglyoxal inactivates NLRP3 via a non-enzymatic, covalent-crosslinking-based mechanism, promoting inter- and intraprotein MICA (methyl imidazole crosslink between cysteine and arginine) posttranslational linkages within NLRP3. This work establishes NLRP3 as capable of sensing a host of electrophilic chemicals, both exogenous small molecules and endogenous reactive metabolites, and suggests a mechanism by which glycolytic flux can moderate the activation status of a central inflammatory signaling pathway.

摘要

NLRP3 炎性小体在疾病中促进炎症,但其活性调节的完整机制尚未完全阐明。在已确定的调节机制中,NLRP3 的共价修饰已成为该蛋白药理学失活的常见途径。在这里,我们表明,糖酵解酶磷酸甘油酸激酶 1(PGK1)的抑制导致甲基乙二醛的积累,这是一种反应性代谢物,其水平增加会减少细胞中 NLRP3 的组装和炎症信号转导。我们发现,甲基乙二醛通过非酶促、基于共价交联的机制使 NLRP3 失活,促进 NLRP3 内 MICA(半胱氨酸和精氨酸之间的甲基咪唑交联)的翻译后交联。这项工作确立了 NLRP3 能够感知一系列亲电化学物质,包括外源性小分子和内源性反应性代谢物,并提出了一种糖酵解通量可以调节中央炎症信号通路激活状态的机制。

相似文献

1
The glycolytic metabolite methylglyoxal covalently inactivates the NLRP3 inflammasome.糖酵解代谢物甲基乙二醛使 NLRP3 炎症小体失活。
Cell Rep. 2024 Sep 24;43(9):114688. doi: 10.1016/j.celrep.2024.114688. Epub 2024 Aug 27.
2
The Glycolytic Metabolite Methylglyoxal Covalently Inactivates the NLRP3 Inflammasome.糖酵解代谢物甲基乙二醛共价失活NLRP3炎性小体。
bioRxiv. 2024 Apr 20:2024.04.19.589802. doi: 10.1101/2024.04.19.589802.
3
A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling.代谢物衍生的蛋白质修饰将糖酵解与 KEAP1-NRF2 信号通路整合在一起。
Nature. 2018 Oct;562(7728):600-604. doi: 10.1038/s41586-018-0622-0. Epub 2018 Oct 15.
4
Glycolytic enzyme PGK1 promotes M1 macrophage polarization and induces pyroptosis of acute lung injury via regulation of NLRP3.糖酵解酶 PGK1 通过调控 NLRP3 促进 M1 型巨噬细胞极化并诱导急性肺损伤细胞焦亡
Respir Res. 2024 Jul 30;25(1):291. doi: 10.1186/s12931-024-02926-8.
5
Glucose metabolite methylglyoxal induces vascular endothelial cell pyroptosis via NLRP3 inflammasome activation and oxidative stress in vitro and in vivo.葡萄糖代谢物甲基乙二醛通过 NLRP3 炎性小体激活和氧化应激诱导血管内皮细胞焦亡:在体和体外研究。
Cell Mol Life Sci. 2024 Sep 13;81(1):401. doi: 10.1007/s00018-024-05432-8.
6
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.小分子通过泛素化和自噬相互作用抑制 NLRP3 炎症:对帕金森病的影响。
Autophagy. 2019 Nov;15(11):1860-1881. doi: 10.1080/15548627.2019.1596481. Epub 2019 Apr 9.
7
Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 Deglutathionylation.谷胱甘肽转移酶 Omega-1 通过去谷胱甘肽化 NEK7 调节 NLRP3 炎性小体的激活。
Cell Rep. 2019 Oct 1;29(1):151-161.e5. doi: 10.1016/j.celrep.2019.08.072.
8
Covalent Targeting As a Common Mechanism for Inhibiting NLRP3 Inflammasome Assembly.共价靶向作为抑制 NLRP3 炎性小体组装的共同机制。
ACS Chem Biol. 2024 Feb 16;19(2):254-265. doi: 10.1021/acschembio.3c00330. Epub 2024 Jan 10.
9
HDAC10 switches NLRP3 modification from acetylation to ubiquitination and attenuates acute inflammatory diseases.组蛋白去乙酰化酶10将NLRP3的修饰从乙酰化转变为泛素化,并减轻急性炎症性疾病。
Cell Commun Signal. 2024 Dec 20;22(1):615. doi: 10.1186/s12964-024-01992-1.
10
Glycolytic reprogramming governs crystalline silica-induced pyroptosis and inflammation through promoting lactylation modification.糖酵解重编程通过促进乳酰化修饰来调控二氧化硅诱导的细胞焦亡和炎症。
Ecotoxicol Environ Saf. 2024 Sep 15;283:116952. doi: 10.1016/j.ecoenv.2024.116952. Epub 2024 Aug 31.

引用本文的文献

1
Optimizing PDIA1 Inhibition as a Strategy to Inhibit NLRP3 Inflammasome Activation and Activity.优化PDIA1抑制作为抑制NLRP3炎性小体激活和活性的策略。
ACS Chem Biol. 2025 Aug 15;20(8):1892-1901. doi: 10.1021/acschembio.5c00221. Epub 2025 Jul 29.
2
Inhibition of NF-κB Signaling by the Reactive Glycolytic Metabolite Methylglyoxal.活性糖酵解代谢产物甲基乙二醛对核因子κB信号通路的抑制作用
bioRxiv. 2025 May 16:2025.05.13.653579. doi: 10.1101/2025.05.13.653579.

本文引用的文献

1
Covalent Targeting As a Common Mechanism for Inhibiting NLRP3 Inflammasome Assembly.共价靶向作为抑制 NLRP3 炎性小体组装的共同机制。
ACS Chem Biol. 2024 Feb 16;19(2):254-265. doi: 10.1021/acschembio.3c00330. Epub 2024 Jan 10.
2
Succinylation of a KEAP1 sensor lysine promotes NRF2 activation.琥珀酰化 KEAP1 传感器赖氨酸促进 NRF2 激活。
Cell Chem Biol. 2023 Oct 19;30(10):1295-1302.e4. doi: 10.1016/j.chembiol.2023.07.014. Epub 2023 Aug 23.
3
Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation.
己糖激酶与线粒体的解离促进了 VDAC 的寡聚化,从而促进了 NLRP3 炎性小体的组装和激活。
Sci Immunol. 2023 Jun 23;8(84):eade7652. doi: 10.1126/sciimmunol.ade7652. Epub 2023 Jun 16.
4
S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling.S-乳酸酰化修饰 KEAP1 可激活 NRF2 信号通路。
Proc Natl Acad Sci U S A. 2023 May 16;120(20):e2300763120. doi: 10.1073/pnas.2300763120. Epub 2023 May 8.
5
Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases.木香烃内酯共价靶向NLRP3的NACHT结构域以抑制炎性小体激活并减轻NLRP3驱动的炎症性疾病。
Acta Pharm Sin B. 2023 Feb;13(2):678-693. doi: 10.1016/j.apsb.2022.09.014. Epub 2022 Sep 25.
6
Exploring the mechanism of action of dapansutrile in the treatment of gouty arthritis based on molecular docking and molecular dynamics.基于分子对接和分子动力学探索达潘苏曲治疗痛风性关节炎的作用机制。
Front Physiol. 2022 Aug 29;13:990469. doi: 10.3389/fphys.2022.990469. eCollection 2022.
7
The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment.非酒精性脂肪性肝病和脂肪性肝炎中的NLRP3炎性小体:治疗靶点与治疗方法
Front Pharmacol. 2022 Mar 8;13:780496. doi: 10.3389/fphar.2022.780496. eCollection 2022.
8
Identification of Tubocapsanolide A as a novel NLRP3 inhibitor for potential treatment of colitis.鉴定土槿皮酸A为一种新型NLRP3抑制剂,具有治疗结肠炎的潜力。
Biochem Pharmacol. 2021 Aug;190:114645. doi: 10.1016/j.bcp.2021.114645. Epub 2021 Jun 4.
9
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor.RRx-001 通过作为一种有效的半胱天冬酶-1 抑制剂来改善炎症性疾病。
Cell Mol Immunol. 2021 Jun;18(6):1425-1436. doi: 10.1038/s41423-021-00683-y. Epub 2021 May 10.
10
α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary human microglia.α-突触核蛋白诱导原代人小胶质细胞中 NLRP3 炎性体介导的白细胞介素 1β 分泌。
Glia. 2021 Jun;69(6):1413-1428. doi: 10.1002/glia.23970. Epub 2021 Jan 28.